Revelation Pharma, a leading nationwide network of 503A and 503B compounding pharmacies, has promoted regulatory expert Nancy Fingerhut to Vice President of Quality Assurance and Regulatory Affairs. In this elevated role, Fingerhut will drive regulatory excellence across Revelation Pharma’s growing network, ensuring the highest industry standards in patient safety and compliance.
Health Technology Insights: OsteoStrong Study Accepted for Publication in The JCEM
Fingerhut joined Revelation Pharma through its acquisition of Lee Silsby Compounding Pharmacy, where she served as Chief Operating Officer. With more than 20 years of experience in regulatory compliance, she has built a reputation for setting the gold standard in quality assurance. Having overseen all facets of a compounding pharmacy’s regulatory and quality assurance programs, she is uniquely equipped to ensure strict adherence to state and federal regulatory compliance across all of Revelation Pharma’s facilities.
“At Revelation, I have the privilege of working with leaders who demonstrate a profound dedication to regulatory excellence.” said Nancy, “It’s for this reason that our mission will be served – an unwavering commitment to quality for our patients.”
Health Technology Insights: GRAIL & Quest Diagnostics Offer Galleri MCED Test Through Quest’s System
Fingerhut’s passion for upholding impeccable ethics and her commitment to patient safety have been the cornerstones of her career. As Vice President of Quality Assurance and Regulatory Affairs, she will spearhead initiatives to uphold and strengthen the ambitious standards Revelation Pharma maintains as it continues its strategic expansion of “buying and building” reputable compounding pharmacies.
“We couldn’t be more excited to have Nancy step into this new role,” said Shawn Hodges, CEO of Revelation Pharma. “Her extensive regulatory expertise and unwavering dedication to quality make her the ideal leader to guide our entire national network. With Nancy at the helm, Revelation Pharma will continue to set the standard of excellence for regulatory responsibility.
Health Technology Insights: Demanding Jobs in Demand? New iCIMS Data Shows Healthcare Hiring Resurgence
To participate in our interviews, please write to our HealthTech Media Room at news@intentamplify.com
Source – prnewswire
